Algeria vs Syria: Cause of death, by non-communicable diseases, ages 60+, female
Algeria
89.1%
in 2021
Syria
89.1%
in 2021
Algeria rank
12th
Syria rank
11th
Cause of death, by non-communicable diseases, ages 60+, female over time
- Algeria
- Syria
How they compare
Syria currently reports 89.1% against 89.1% in Algeria, a difference of 0.0%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Syria ahead.
Algeria ranks 12th and Syria ranks 11th of 185 countries.
Syria has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Algeria | Syria | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 93.3% | 96.2% | 2.8% | Syria |
| 2010s | 93.7% | 94.7% | 1.0% | Syria |
| 2020s | 84.4% | 91.0% | 6.6% | Syria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, female, Algeria or Syria?
- Syria, at 89.1% against 89.1% in Algeria as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, female between Algeria and Syria?
- 0.0%, with Syria ahead.
- How many years of comparable data are there for Algeria and Syria?
- 6 years are reported by both, from 2000 to 2021.
- How do Algeria and Syria rank globally for cause of death, by non-communicable diseases, ages 60+, female?
- Algeria ranks 12th and Syria ranks 11th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, female (% of total female deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 60+ due to non-communicable diseases divided by number of all female deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.